|
GB9423928D0
|
|
Vaccine
|
|
GB9323754D0
|
|
Vaccine
|
|
US5395609A
|
|
Synthetic peptides for use in tumor detection
|
|
GB9217124D0
|
|
Medical treatment
|
|
GB9209298D0
|
|
Process for the preparation of an il-ig fusion protein,dna constructs,and oligonucleotides primers for use therein
|
|
GB9201191D0
|
|
Diagnostic and therapeutic compounds
|
|
GB9120944D0
|
|
Modified human serum albumin
|
|
GB9116925D0
|
|
Novel reagent for tumour imaging and therapy
|
|
GB9115192D0
|
|
Cancer treatment
|
|
GB9114973D0
|
|
Production of radiopharmaceuticals
|
|
GB9114657D0
|
|
Diagnostic compounds
|
|
GB9108652D0
|
|
Immunoreactive compounds
|
|
GB9107172D0
|
|
Therapeutic and diagnostic compounds
|
|
GB9106309D0
|
|
Novel diagnostic reagent for in vivo thrombosis imaging
|
|
GB9104257D0
|
|
T-cell activator fusion proteins
|
|
GB9101436D0
|
|
Diagnostic and therapeutic compounds
|
|
GB9101435D0
|
|
Therapeutic and diagnostic compounds
|
|
GB8914020D0
|
|
Synthetic peptides for use in thrombus detection
|
|
GB8914021D0
|
|
Anti-tumour cytotoxic t-cells and their production
|
|
GB8914022D0
|
|
Synthesis of complementary specific binding peptides
|
